Overview of treatment plan quality in a high dose rate prostate brachytherapy workflow

被引:0
|
作者
Panetta, J. V. [1 ]
Veltchev, I. [1 ]
Horwitz, E. [1 ]
Hallman, M. [1 ]
Wong, K. [1 ]
Price, R. A. [1 ]
Ma, C. M. C. [1 ]
机构
[1] Fox Chase Canc Ctr, Dept Radiat Oncol, 333 Cottman Ave, Philadelphia, PA 19111 USA
关键词
modality combinations: Varian Varisource/US; Elekta microSelectron/CT; ULTRASOUND; MONOTHERAPY; CANCER; CT; DOSIMETRY; PROGRAM;
D O I
10.1016/j.brachy.2024.08.255
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PURPOSE: High dose rate brachytherapy (HDR-BT) has been shown to be an effective treatment for prostate cancer, with treatment plan quality dependent on a number of factors. In this work, we report on the overall performance of our ultrasound (US)-based workflow and the impact of several treatment-specific variables. METHODS AND MATERIALS: Patients who underwent HDR-BT (boost, monotherapy, and retreatment) using Varian Bravos/US from 2021 to 2023 were sampled for this study. Treatment plan quality was analyzed and plans were categorized with regard to a number of metrics, including: prostate volume, treating physician, planning physicist, number of needles included, estimated planning time, rectum-prostate separation, and bladder-prostate separation. The performance of this program was compared to the performance of our program using previously used RESULTS: Plan quality for our Bravos/US workflow was shown to be consistently above acceptability criteria for all personnel involved; on average: prostate V100%: 98.9% f 0.1%, rectum V75%: 0.04 f 0.01 cc, bladder V75%: 0.06 f 0.01cc, urethra V125%: 0.00 f 0.00 cc. Prostate coverage was statistically improved with this workflow compared to that using our previous modalities. There was a statistical correlation between organ-at-risk sparing/prostate coverage ratio and prostate volume, number of needles/prostate volume, bladder-prostate separation, and rectum-prostate separation. There was no correlation between plan quality and planning time. CONCLUSIONS: Our US-based HDR-BT program led to target coverage and organ-at-risk sparing that exceeded department thresholds. Results were acceptable regardless of the personnel involved and improved plan quality was obtained using more needles/prostate volume and increased spacing between the prostate and the rectum and bladder. (c) 2024 American Brachytherapy Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:698 / 704
页数:7
相关论文
共 50 条
  • [1] Rectum dose reduction and individual treatment plan optimization for high-dose-rate prostate brachytherapy
    Boelling, Tobias
    Moustakis, Christos
    Elsayed, Hassan
    Mueller, Stefan-Bodo
    Weining, Christoph
    Reinartz, Gabriele
    Ernst, Iris
    Willich, Normann
    Koenemann, Stefan
    BRACHYTHERAPY, 2007, 6 (04) : 280 - 285
  • [2] Instant plan quality prediction on transrectal ultrasound for high-dose-rate prostate brachytherapy
    Wang, Tonghe
    Feng, Yining
    Beaudry, Joel
    Nunez, David Aramburu
    Gorovets, Daniel
    Kollmeier, Marisa
    Damato, Antonio L.
    BRACHYTHERAPY, 2025, 24 (01) : 171 - 176
  • [3] High dose rate brachytherapy in the treatment of prostate cancer
    Frank Vicini
    Carlos Vargas
    Gary Gustafson
    Gregory Edmundson
    Alvaro Martinez
    World Journal of Urology, 2003, 21 : 220 - 228
  • [4] High dose rate brachytherapy in the treatment of prostate cancer
    Rodriguez, RR
    Demanes, J
    Altieri, GA
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1999, 13 (03) : 503 - +
  • [5] High dose rate brachytherapy in the treatment of prostate cancer
    Vicini, F
    Vargas, C
    Gustafson, G
    Edmundson, G
    Martinez, A
    WORLD JOURNAL OF UROLOGY, 2003, 21 (04) : 220 - 228
  • [6] High dose rate prostate brachytherapy
    Nickers, P.
    Blanchard, P.
    Hannoun-Levi, J-M
    Bossi, A.
    Chapet, O.
    Guerif, S.
    CANCER RADIOTHERAPIE, 2013, 17 (02): : 118 - 124
  • [7] Role of high dose rate brachytherapy in the treatment of prostate cancer
    Ghilezan, M.
    CANCER RADIOTHERAPIE, 2012, 16 (5-6): : 418 - 422
  • [8] High dose-rate brachytherapy in the treatment of prostate cancer
    Mendez, Lucas C.
    Morton, Gerard C.
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2018, 7 (03) : 357 - 370
  • [9] Low Dose Rate Prostate Brachytherapy Quality Assurance and Treatment Evaluation
    Butler, W.
    Chen, Z.
    MEDICAL PHYSICS, 2011, 38 (06)
  • [10] An Automated Treatment Plan Quality Assurance Program for Tandem and Ovoid High Dose-Rate Brachytherapy
    Tan, J.
    Shi, F.
    Hrycushko, B.
    Medin, P.
    Stojadinovic, S.
    Pompos, A.
    Yang, M.
    Albuquerque, K.
    Jia, X.
    MEDICAL PHYSICS, 2015, 42 (06) : 3594 - 3594